Track record · closed signal

The Interpublic Group of Companies, Inc. (IPG) — closed signal from October 10, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 8, 2026.

Predicted vs. what happened

IPG price · publication thesis → realized outcomesplit-adjusted
$26.76 Published $31.58 Target $24.57 Window close $28.24 Peak
$26.00 – $27.00Entry zone — fair-value band
$26.76Published — price the day we called it
$31.58Target — the price the thesis aimed for
$28.24Peak — highest point inside the window, not a realized return
$24.57Window close — end-of-window price, context only

What happened

Partial

Reached 31% of the predicted growth at its peak, without hitting the target.

Peak price
$28.24
peak on October 22, 2025 — not a realized return
Peak gain
+5.5%
peak, from the publication price
Window close
$24.57
end-of-window price, context only
Days to target
—
Window
October 10, 2025 – January 8, 2026

The thesis — published October 10, 2025

Predicted growth
+18%
over the measurement window
Target price
$31.58
the price the thesis aimed for
Entry zone
$26.00 – $27.00
the fair-value band we waited for
Price at publication
$26.76
published October 10, 2025
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

IPG looks set for a short-term rebound after a pullback. Recent news showed it earned global ISO quality certifications and won major work from Bayer Consumer Health, easing worries about slower growth. Buying interest looks stronger than usual, and advertisers often release more budget late in the year. A 3-month recovery is possible if onboarding goes smoothly and the economy stays steady.

Primary drivers

  • Price fell hard and looks ready to bounce as buying interest picks up
  • Winning Bayer Consumer Health work should bring new projects and added fees
  • New global ISO quality certifications reassure big clients about reliability
  • Many advertisers free up fresh spending near year-end, lifting activity

How it played out

IPG: target was not reached

Lyra published IPG at 26.76 on 2025-10-10 with 18% expected growth and a 31.58 target. The thesis pointed to a hard price fall that looked ready to bounce, stronger buying interest, Bayer Consumer Health work, global ISO quality certifications, and year-end advertiser spending.

Inside the window, IPG rose to 28.24 on 2025-10-22, a 5.5% peak gain. That was the high point in the data, and it stayed below the 31.58 target. The stock ended at 24.57 on 2026-01-08. The rebound happened only partly. The target was missed.

What happened during the window

On November 26, 2025, Omnicom said it had completed its acquisition of Interpublic after receiving all necessary regulatory approvals. Interpublic shareholders received 0.344 Omnicom shares for each Interpublic share, and legacy Interpublic shareholders owned about 39.4% of the combined company.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All IPG signals